EMEA-000035-PIP02-09-M02
Key facts
| Active substance |
Tiotropium bromide (monohydrate)
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0005/2015
|
| PIP number |
EMEA-000035-PIP02-09-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of asthma
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000035-PIP02-09-M02
|
| Compliance opinion date |
27/05/2016
|
| Compliance outcome |
positive
|